Surgery in combination with endocrine therapy can provide better treatments for the patients with estrogen receptor (ER) positive, progesterone receptor (PR) positive and human epidermal growth factor receptor 2 (HER2) positive breast cancer [3]. This evidence concerns the gene ESR1 and breast carcinoma.